Good post Dwud....

First of all, of course i predicted a further price drop. That is why i sold??? If i thought it would go up short term, i would have kept my shares, right? And, i was correct. I sold 40% of my shares at .83 and 40% at .81, and it hit .665 intra-day yesterday, (which i did not get my 15% filled at .68). I am simply averaging down based on the information i have collected and the perceived near short term future.

Now, back to information. There is absolutely no way, IMO, that Medify can penetrate 10% of the market. Per Medify's website, there are ONLY 90,000 doctors in the NHS. They will be the first to test/use the product. Even IF every doctor tests this product out for the first year, that is only 6% penetration. We know EVERY doctor will not test it. Also, the majority of the trusts have NOT been presented to. Not only do the trusts need to schedule a presentation, sit through and absorb a demenstration, they also then need to meet and discuss the presentation and decide if they would like to use it for a period of time on trial to see if they find the device useful, or find it cumbersome, complicated and too expensive. Remmeber, older phyisicians are conservative. And lastly, the NHS is similar to the US Government. Things run very, very, very slowly and must go through multiple tiers with each decision. In final, i am not sure who is telling you that 10% penetration of patient notes is still on schedule, but i find it extremely hard to beleive based on information i have collected, and based on misinformation stated in previous articles.

As a note, i count 'within first year' as the time Medify Solutions went public. If they have not had a revenue contract yet with MedifyRemote (0% penetration), do you still think the can obtain 10% in next 8 months?

I think a much more conservative number may be within three years, and a realistic number may be two years.

Messages Restored. Thank you Matt!

Now to continue discussion.

One of the biggest factors of being in this company was for MedifyRemote. Back approximately two months ago, the European Business made public in an article that the Doncaster Trust was the first trust that MedifyRemote landed. Now, the most recent article is headlined "Medify proves concept with first revenue contract" Note within the article that this does not mean just the education platform, as it specifically states "Medify Solutions", and is not specifically stating the continuing education platform.

So, what gives? Obviously Doncaster Trust has NOT been rolled out to like previously thought. This not only makes me 'unsure/uneasy' of the information that the company is supplying to investors, but knowing that the Doncaster Trust and the entire mobile patient notes program is not where i figured it would be at this time was my basis for selling a large part of my investment. IMO, there is no possible way the company can obtain 10% penetration within the first year.

Speaking with a manager within a trust, this product still needs to be demonstrated to the physicians within EVERY trust, and if they like the product, they will test it (a small sample). This is within each trust (300+ of them). They DO NOT have to use the product if they do not like it. In no way is the NHS going to force a physician to use it, the physicians are in control, NOT the NHS directors/management.

I feel this will take longer. Yes, longs are ok, it WILL be a great company. I just feel their are many better short term plays that are currently making a profit, growing and more importantly, the stock price/interest is currently their.

I still own a portion, as this is a great company. But not where i thought it was previously. Pumpers, save your "then move on" line, because i am NOT moving on. I would like to debate and share info - see how others feel.

And Dwudman, please refrain from name calling. It is an annoying, immature antic. People on this board have their OWN money invested. If they have an opinion, let them state it without you ripping them. Very immature and unprofessional.

Thanks, and good health to all!

Thanks Lloyd. I sent message to Admin (matt)....

We need intelligent debate here on both sides. Oledudes, there was absolutely nothing wrong with my posts. Their is reason for concern, and we all should be debating it. That is what this board is for. You have now deleted 2 of my messages.

Obviously, we should all be concerned. Dropping 10% a day for the last how long? 1.55 down to .665 (intra day low today). If everything was peachy, it would NOT drop this fast. And quit blaming every day on the MM's. Oldest excuse in the book.

Everything is NOT peachy, i find a flaw and come here to discuss, and Oledudes deletes to protect his interest. I am NOT a basher, but you can now obviously be considered a pumper at this point.

Hopefully people keep on selling....

Simply creates an unbeleivable buying opportunity.

Without the big news (MedifyRemote rollout #'s), it will continue to slowly sink. I Kept 20%, and my strategy is to purchase back in increments of 20% on each 15% drop. I was banking on rollout #'s ever since the article came out in the European Business, and we have not seen it as of yet. I find that extremely strange.

Not sure what everyones investment strategy is, but if you do not have extra funds on the side, it may be somewhat wise to sell part of your position on the beginning of the day runup (seems like it upticks early, downticks rest of day), and buy increments as this goes downward. Basicallly can double your shares while investing the same amount, and if the big news hits, you will have shares and will not miss boat.

For investment purposes, would be great to fast-forward one year to see us sitting at $2-$5. But who wants to age?

I hate when i type a long message and it doesnt take UGGGH!

Oledudes.....

I am thinking low .60's or quite possibly high .50's.

I thought there would be very strong support at .75, but yesterday it easily dipped below .75 on mediocre volume. I am simply taking most off the table and trading in a couple others, and i will jump back in at lower prices (up share volume without investing any more $$$$$).

There is no doubt in my mind where this company will be. However, it seems it will take a little more time than expected. Based on last press release, there are a couple other short-term plays i like better at this time....but do not get me wrong, there is only one other long-term play out there i find comparable, and i still prefer Medify between the two.

What i do not like....

"First revenue contract - only 55 users."

Many obviously look at that statement and the initial reaction is "Whoopie". Looks like the revenue gained from this is going to amount to about a whopping 1,000 dollars. With 80 million shares outstanding, that is not a whole lot.

That didnt bother me too much. You have to start somewhere. What i DID NOT LIKE though, was 'First Revenue Contract'. That is what hit me hard. What about MedifyRemote and the Doncaster Trust? Looks like our patient notes program is not where i thought it was.

What i gather is that significant revenue is going to take much longer to get than they previously stated in an article when they stated that they could penetrate 10% of the market within a year. Doesnt look like it will be that close.

I sold 80% of my position today because i strongly feel the price of this will drop much lower, and in the future i will be able to get in a decent amount less.

Luv....

Was that test a test simply to make sure the message board was working because not one post has been initiated in 24 hours? Pretty shocking, but understandable since all subjects have been exhausted ad nausem and we are 'still' waiting for MedifyRemote rollout numbers.

Seems we are all falling asleep waiting for rollout news. Should have come almost 2 weeks ago. I am more than slightly disappointed in the lack of guidance of MedifyRemote.

One thing about this stock's price....

It is a traders dream and longs better have a strong heart. The volatility of this issue is sometimes mind-boggling - one heck of an emotional stock for the weak minded.

Regarding MFYS and leaving pinks....

Their was a great article by 'The Business' (which, unfortunately is no longer available) that interviewed Jonathan Bryant about 1 month ago. In that article, it stated that Medify will in time seek Junior Nasdaq or Nasdaq proper listing.

Good scoop Lloyd.

I think you will recoup your losses here. Just need some patience.

Medify Solutions will be adding to their investors relations tab on their website which will add much more relevant content as to what has happened, what is happening and where they are going.

Information is the key to contenting hungry investors.

Welcome Lloyd! Couple of questions:

-Care to share what Andrew had to say with the rest of the board?
-What other two small-caps were you burnt by (ticker symbols)?
-How were you referred into buying Medify?

Thanks, and good health to you sir!

Lem makes a good point. Could possibly be his company they are buying.

I could not find a thing on nitesprite using a google search, so Lem may be correct.

Must be a large sell limit block at .98

Alot of big block shares are being absorbed at this level. I imagine there will be some strong resistance at 1.00 also. We had alot of consolidation under 1.00, so it might take a little bit to push through 1.00, but when it does it should fly nicely.

Of course, the rescilliance of this stock never ceases to amaze me sometimes.

Oledudes....

Im done with that board. I just want to post a few messages to discredit the 2 yuppies, so when new investors come to read up, they will disregard the yuppies posts. And no, i have NEVER come close to selling even one share of this company, which i think most of you know :)

I cannot stress this enough (FBGO)....

If a service or another investor is recommending a stock, dont buy it until you RESEARCH it. Do NOT depend on another persons research. All you had to do with FBGO is read their pervious filings and PR's.

Would you feel comfortable investing in a company that admits it has lost money going backward, and to stay afloat they have issued stock AND taken on debt (notes payable and with it comes interest expense)? They even stated they have less than 24 months before their newly raised capital runs out. And they are banking all of this on extending their Bingo service? Maybe a market of about 100 million dollars globally with no competition.

At least Bellwether was 'man' enough to admit their mistake and email it public. They do get a plus with me for that.

Interesting. I wonder if continuous education is required for some employees. If so, wonder how many.

I am only investing in this company because of MedifyRemote. But this could have an equal impact. Unbeleivable.

Lem...

Where does the 400# per course come from?

There is an estimated 1.4 million people employed by the NHS.

I hope no one here invested in Bellwether's Bingo junk. Right as soon as i received my email from Bellwether on it, i quickly researched it. All the DD i did came up JUNK. I do not know how Bellwether could even put there name behind that crap, but they lost ALOT of credibility from me on that one. Alot.

If they recommend another like that company, i think i will begin to call Bellwether a classic pump and dump company, taking advantage of their clients.

They were right on Medify Solutions, but i think it may have been more because of chance/luck than actual research. Keep an eye on Bellwether guys. Bidsmack/Whybuy may have actually 'luckily' been right about one thing.

Your no dummy....

I am for puting myself in danger of losing my job from all the research i have been doing!

;)

Good Question posed on other board.....

w1ze07513 wrote "Looks like we're climbing back up fellas. Hope this holds on for a while. Any explanation as to what caused this?"

I have a very solid feeling why.

Investor relations had not responded to investor-related questions via email for almost 3 weeks. One of the directors, yesterday in fact, got caught up on a large queue of outstanding email inquiries.

The reason why the stock had been going down was simple. Management has been to busy (including being out of the office for long periods of time) to reply. If they are replying, THEY ARE NOT SELLING.

The effect that this caused was a loss of confidence in the company by retail investors, since the company failed to answer any email inquiries. The typical retail investor did what he felt was the right thing - sell.

One of the directors, namely Trevor Bone, got caught up yesterday. This not only re-assured current investors, but re-assured former investors to the point that they came back on board.

Remember, this is a new company that is at a critical early stage of SELLING. I am very confident that in time, they will have their own IR department who's job will be simply to inform investors.

Stay patient, and good health to all!

One amazing thing about this stock....

For having 80 million shares outstanding, and only trading 1.5% to 2% of that daily, this sure bursts through resistances (low or high). That bascially tells me that their are TON of long-term investors holding onto this. No other way a stock with so many outstanding and float shares could move up and down this fast.

Alot of long-term holders out there that will not part with it. Thats for sure.

I would LOVE to have shorted that....

Bingo junk.

Welcome JMD (more)...

The company is actually not sitting idle. They are extremely busy. Possibly the busiest they will ever be. This is the critical time of successfully demonstrating all products, and assissting new users in transitioning towards their product.

In five years, they can more-or-less sit back and draw a check. But right now, they are busting behind to aggressively sell, sell, sell.

Another thing to keep in mind: compared to other pink sheets, Medify is already a large company. They have a rather large market capitalization for a new-start small-cap, and are consistantly in the top 40 list for dollar volume leaders as a pinksheet, and frequently make the top 10 list. Not bad at all for first month of trading.

I have no idea who NiteSprite is/was. Just read the press release. I think they are going to help with the Online Medify Continuing Learning program, and have nothing to do with MedifyRemote. MedifyRemote is already in place - partners, content, devices and everything is already in place.

I beleive Pervasic is the software company that helped establish the software to communicate in between all hardware in the MedifyRemote project.

Lem, what did you here.

Not sure where you are coming from on this one. Medify gets 20% of revenue though. Orange 40% and Oracle 20% and i beleive it was Pervasic with 20%. What does that have to do with stalling of news?

Had contact with two 'in-the-knows' today....

Posted earlier that my contact within the NHS has setup a demonstration at his trust for later this month. Not huge news, but displays that other trusts other than Doncaster are lining up.

Just had breif communication with Trevor Bone, Co-Director of Medify Solutions. This you may all like. It seems that within two weeks, there will be "...an information pack covering trading, financials and future plans which will be available to ALL investors at the same time via the website within the next couple of weeks."

This information should not only answer alot of outstanding questions we have, but also be available to ALL of us.

This reply was in response to my questions pertaining to: 1)recent shareholder value decline 2)MedifyRemote rollout to Doncaster and all other trusts rolled out to 3)Device quanitity rollout 4)If earnings of US$1.50 withing one year was still attainable as recently stated and 5)If Junior Nasdaq or Nasdaq Proper were still future priorities like a recent article suggested, and if so, the timetable.

I am going to attempt to give him a phone call later today (gonna try and get out of the office). If i here more good stuff, i will fill everyone in.

Good health to all!

Michael

Alright, good work. Looks like we have a limited number of posts on here though. I dont think anyone except company bashers post 15 messages a day though, so we should be fine.